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Introduction. We present a case with acute DIC probably caused by a type I endoleak after endovascular aneurysm repair
(EVAR).
Case report. An 84-year-old male underwent elective EVAR of a 7 cm sized infrarenal aortic aneurysm and developed five
months later an acute DIC associated with an endoleak type I. After successful endovascular stent-graft extension the DIC
resolved.
Discussion. Endoleak type I is not described to be related to DIC, however as the endovascular stent-graft extension did
abolish both, endoleak and the DIC in our case. We therefore suggest that a type I endoleak can cause acute DIC.
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Disseminated intravascular coagulopathy (DIC) is a
known serious complication associated with abdomi-
nal aortic aneurysms (AAA), especially in cases of
rupture or dissection.1 DIC has rarely been reported
in association with an endovascular aneurysm repair
(EVAR).
We describe the first reported case of DIC-associated
type I endoleak after EVAR.
Case Report
An 84-year-old man with myelodysplastic syndrome
and stable chronic thrombocytopenia of 91109/l un-
derwent elective endovascular repair of a 7 cm sized
infrarenal aortic aneurysm in May 2003. Four weeks
postoperatively, follow-up computed tomography
(CT) demonstrated an type I endoleak arising from the
left iliac limb which was treated with endovascular
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internal iliac artery.
Four months later, the patient developed severe
spontaneous oral mucosal bleeding, ecchymosis and
petechia in the lower limbs. On admission (29th Octo-
ber 2003) the lowest coagulation values were as follow
(Table 1): decreased platelet count of 63 109/l (nor-
mal levels: 150e400 109/l), prolonged prothrombin
time (INR: 1.51), activated partial thromboplastin
time of 44 sec. (normal: 26e35 sec.), severely de-
creased fibrinogen (0.4 g/l; normal: 1.8e3.5) and in-
creased fibrinogen degradation products (D-dimer
4517 mg/l; normal: <400). Before admission, the pa-
tient’s coagulation screen had been in normal range
until September 2003. The current laboratory studies
were consistent with an acute DIC. An underlying
trauma, infection or malignancy could clinically be
excluded. Inflammatory causes for DIC could be ex-
cluded as well by extended laboratory analysis. CT
of the abdomen revealed an type I endoleak arising
from the distal right iliac limb which was confirmed
by angiography (Fig. 1). However, a retroperitoneal
hematoma developed at the puncture site. Since
risk of open surgical repair of the endoleak was con-
sidered to be high, a transfemoral endovascularC-ND license.
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of the right common femoral artery. Over a guidwire
a stent-graft (Talent AAA, Medtronic AVE, USA)
was inserted, advanced to the desired position under
fluoroscopy and exactly deployed in the right com-
mon iliac artery in a partially overlapping fashion in
order to provide secure endoleak exclusion without
obstructing the ostium of the internal iliac artery.
Fig. 1. Retrograde transfemoral angiography confirmed an
endoleak type I in the distal right iliac artery.
Table 1. Laboratory analysis outlining coagulation parameters at
baseline, at one and at 30 months follow-up after stent graft
placement
Coagulation
parameters
At baseline 1 month after
stent placement
30 months after
stent placement
Platelet count
[150e400 109/l]
63 53 130
INR* 1.51 1.2 1.2
aPTT [26e35 sec.]* 52 33 30
Fibrinogen
[1.8e3.5 g/l]
0.4 Not available 1.3
D-dimer
[<400 mg/l]
4517 Not available >5000
* INR and aPTT denote international normalized ratio and
activated partial thromboplastin time, respectively.After balloon dilatation and apposition of the stent-
graft to the vessel wall, final angiography showed nei-
ther endoleak nor contrast media extravasation
(Fig. 2). However, due to repeated passage of endo-
vascular instrumentation a flow-limiting dissection
of the right common femoral artery occurred necessi-
tating surgical repair at the same day. After the proce-
dure, the patients recovered fast. Within five days
after endoleak repair all of the coagulation parameters
measured returned to normal range except for a
slightly raised aPTT (37.5 sec). Eight days after the in-
tervention, the patient was discharged after an
uneventful postoperative recovery. Overall, a total
amount of 5 units of red cell concentrate, 15 units of
fresh frozen plasma and 6 units of platelets were
transfused.
During follow-up the patient was doing fine with
no further complication. He experienced minor but-
tock claudication as a result of coiling of the left inter-
nal iliac artery. Coagulation parameters remained
normal with stable near normal fibrinogen (1.3 g/l)
Fig. 2. Angiography after deployment of a Talent AAA
stent-graft showed successful exclusion of the endoleak and
preserved blood flow through covered stent-grafts.EJVES Extra Vol 12, November 2006
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follow-up (Table 1). Fibrinogen degradation product
still remained increased. CT-scan of the abdomen
demonstrated sustained exclusion of the endoleak.
Discussion
Clinically overt DIC affects about 4% of patients with
AAA2 and aneurysmal size correlates well with
markers of blood coagulation and fibrinolysis. 3 Until
recently, DIC has not been reported to be caused by
an endoleak following EVAR. A fatal consumptive
coagulopathy after endovascular stent-graft repair of
AAAwas reported by Cross and colleagues.4 They de-
scribed a case in which prolonged and repeated pas-
sage of endovascular instrumentation may perturb
the endothelium and stimulate procoagulant activity
leading to consumptive coagulopathy.4
As coagulation parameters were normal directly af-
ter EVAR in our patient, the stent itself was not con-
sidered to be the cause for DIC. The course of the
coagulation parameters showed a striking deteriora-
tion associated with the occurrence of the endoleak.
After successful exclusion of the endoleak by using
an iliac stent-graft extension, the DIC rapidly resolved
supporting our hypothesis that the DIC was related to
the endoleak. FFP is an effective way to stabilize coag-
ulation, but we were unable to correct the coagulation
after administration of overall 13 FFP to the date of
graft extension, assuming that the endoleak is the pro-
moter for DIC. A possible pathomechanism could be
the liberation of coagulant material from the turbulent
jet flow into the circulation or an accumulation of clot-
ting factors at the site of the injured vessel wall as has
been reported in ruptured or dissecting AAA by ten
Cate and colleagues.1EJVES Extra Vol 12, November 2006Pre- and perioperative management of DIC con-
sists of platelet transfusion and clotting factor replace-
ment. Generally, it is agreed upon that operation
provides the best hope of cure in AAA-associated
DIC. However, successful treatment with endovascu-
lar stent-graft repair of DIC-associated aortic dissec-
tion is an acceptable alternative as reported by
Sakamoto and colleagues.5
We conclude that a type I endoleak after EVAR can
cause acute DIC, since endovascular stent-graft exten-
sion did abolish both, endoleak and DIC in our case.
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